CCEL
CryoCell International Inc
NYSE MKT: CCEL · HEALTHCARE · MEDICAL CARE FACILITIES
$3.51
-0.28% today
Updated 2026-04-30
Market cap
$29.56M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.32
Dividend yield
3.84%
52W range
$3 – $6
Volume
0.0M
CryoCell International Inc (CCEL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-8.52%
Operating margin
9.96%
ROE
129.20%
ROA
0.19%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $17.18M | $-2.81M | 64.68% | -17.23% | -16.36% |
| 2007 | $17.46M | $-5.01M | 62.24% | -26.76% | -28.67% |
| 2008 | $17.28M | $-760419.00 | 64.62% | -1.89% | -4.40% |
| 2009 | $16.33M | $1.42M | 72.24% | 10.24% | 8.73% |
| 2010 | $17.64M | $3.41M | 74.46% | 18.27% | 19.34% |
| 2011 | $17.92M | $-2.10M | 75.45% | -1.54% | -11.69% |
| 2012 | $17.97M | $-6.31M | 72.80% | -9.52% | -35.11% |
| 2013 | $18.99M | $27436.00 | 71.98% | 8.96% | 0.14% |
| 2014 | $20.13M | $553623.00 | 72.02% | 9.84% | 2.75% |
| 2015 | $21.09M | $8.11M | 73.30% | 13.91% | 38.43% |
| 2016 | $23.13M | $-1.32M | 75.03% | 1.87% | -5.71% |
| 2017 | $25.38M | $2.32M | 73.51% | 19.72% | 9.12% |
| 2018 | $29.22M | $-854824.00 | 70.77% | 17.76% | -2.93% |
| 2019 | $31.82M | $2.29M | 68.46% | 15.91% | 7.20% |
| 2020 | $31.15M | $3.62M | 68.99% | 24.60% | 11.64% |
| 2021 | $28.88M | $2.08M | 68.88% | 13.91% | 7.21% |
| 2022 | $30.34M | $2.77M | 71.02% | 13.27% | 9.14% |
| 2023 | $31.34M | $-9.52M | 73.07% | -39.26% | -30.38% |
| 2024 | $31.99M | $402095.00 | 75.15% | 10.88% | 1.26% |
| 2025 | $31.57M | $-2.43M | 76.63% | 1.53% | -7.70% |